Inclusive Investor Relations, Equity Development

Equity Development

We help companies communicate with all investors by providing research and access to management. Equity Development makes Investor Relations genuinely inclusive.

Inclusive Investor Relations

We help companies communicate with all investors. We help all investors better understand those businesses.

Equity Bottom-Up

<ul><li>ECO Animal Health Group has announced that the European Commission has adopted the decision granting EU marketing authorisation (MA) for ECOVAXXIN® MS, the poultry vaccine against Mycoplasma synoviae.</li><li>This important authorisation is key to commercialisation of this, the first of several major products under development to receive approval.</li><li> As the Group notes, the MA has been issued over a month earlier than anticipated.</li></ul>

ECO Animal Health Group has announced that the European Commission has adopted the decision granting EU marketing authorisation (MA) for ECOVAXXIN® MS, the poultry vaccine against Mycoplasma synoviae.This important authorisation is key to commercialisation of this, the first of several major products under development to receive approval. As the Group notes, the MA has been issued over a month earlier than anticipated.

Early EU authorisation for ECOVAXXIN® MS

Eco Animal Health

Early EU authorisation for ECOVAXXIN® MS